ONCAlert | Upfront Therapy for mRCC
Videos  >  

Exploring the Potential of CAR T-Cell Therapy in Head and Neck Cancer

Sophie Papa, PhD, MBBS, MRCP
Published Online:8:13 PM, Thu May 25, 2017

Sophie Papa, PhD, MBBS, MRCP, King’s College London in the United Kingdom, discusses chimeric antigen receptor (CAR) T-cell therapy for patients with head and neck cancer.
Copyright © TargetedOnc 2019 Intellisphere, LLC. All Rights Reserved.